期刊文献+

ST段再抬高对急性心肌梗死溶栓患者近期预后的影响

Influence of ST segment re-elevation on the recent prognosis posterior to acute myocardial infarction
下载PDF
导出
摘要 目的:探讨急性心肌梗死(AMI)静脉溶栓治疗后ST段再抬高对患者近期预后的影响。方法:将首发98例患者按静脉溶栓治疗后心电图有无ST段再抬高分为ST段再抬高组(A组)和ST段无再抬高组(B组),比较两组危险因素、再灌注心律失常、心功能、梗死后心绞痛及并存疾病等。结果:两组伴发糖尿病、原发性高血压及吸烟比较,无统计学意义(P>0.05);两组梗死部位、再灌注心律失常、心功能分级、梗死后心绞痛比较,无统计学意义(P>0.05)。结论:AMI静脉溶栓治疗后短暂的ST段再抬高可作为心肌再灌注成功的一种临床表现,对患者近期预后无不良影响。 Objective: To explore the influence of ST segment re-elevation on the recent prognosis posterior to AMI. Methods: 98 patients were divided into two groups: ST segment re-elevation group (A group) and none-ST segment re-elevation group (B group). Cardiac arrhythmia after reperfusion, heart function, postinfarction angina pectoris and complications were analyzed in two groups. Results: There were no difference of concomitant diabetes mellitus, essential hypertension, smoking rate between two groups (P 〉 0.05). Cardiac arrhythmia after reperfusion, cardiac function grade, postinfarction angina pectoris were compared in two groups, but there were no difference between two groups (P 〉 0.05). Conclusion: Transient ST segment re-elevation after intravenous throm-belytic therapy in patients with AMI could be considered as one clinical performance of successful reperfusion of myocardium, which has no negtive influence on the recent prognosis posterior to AMI.
出处 《中国药物应用与监测》 CAS 2008年第3期28-29,63,共3页 Chinese Journal of Drug Application and Monitoring
关键词 急性心肌梗死 静脉溶栓治疗 ST段再抬高 Acute myocardial infarction Intravenous thrombolytic therapy ST segment re-elevation
  • 相关文献

参考文献5

二级参考文献24

  • 1杨跃进.经皮冠状动脉介入治疗中无再流的诊断、治疗和预防[J].中华心血管病杂志,2004,32(7):662-664. 被引量:57
  • 2Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation, 2002,105 : 656-662.
  • 3Brener SJ, Barr LA, Burchenal JE, et al. Randomized, placebo-controlled trial of platelet glycoprotein Ⅱ b/Ⅲ a blockade with primary PTCA Organization and Randomized Trial ( RAPPORT ). Circulation, 1998,98 : 734-741.
  • 4Montalescot G, Barragan P, Wittenberg O, et al. For the ADMIRAL Investigators. Platelet glycoprotein Ⅱ b/Ⅲ a inhibition with coronary stenting for acute myocardial infarction. N Eng J Med, 2001, 344:1895-1903.
  • 5Stone GW, Grines CL, Cox DA, et al. Comparision of angioplasty with stenting, with or without abciximab, in acuete myocardial infarction. N Eng J Med, 2002, 346 : 957-966.
  • 6Neumann FJ, Blasini R, Schmitt C, et al. Effect of glycoprotein Ⅱ b/Ⅲ a receptor blockade on recovery flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infction. Circulation, 1998, 98 : 2695-2701.
  • 7Petronioa AS, Rovai D, Musumeci G, et al. Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty. Euro Heart Journal, 2003, 24: 67-76.
  • 8The RESTORE Investigators. Effects of platelet glycoprotein Ⅱ b/Ⅲ a blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation, 1997, 96: 1445-1453.
  • 9Lincoff AM. Trial of platelet glycoprotein Ⅱ b/Ⅲ a receptor antagonists during percutaneous coronary revascularization. Am J Cardiol, 1998, 82:36-42.
  • 10Danzi GB, Sesana M, Capuano C, et al. Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function. Am J Cardiol, 2004, 94:35-39.

共引文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部